Crossmark

Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study

Crossref DOI link: https://doi.org/10.1186/s40644-022-00515-w

Published Online: 2023-01-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Lu

Wang, Lei

Tan, Yuchuan

Dan, Hanli

Xian, Peng

Zhang, Yipeng

Tan, Yong

Lin, Meng

Zhang, Jiuquan https://orcid.org/0000-0003-0239-6988
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82071883)

General project of Chongqing Natural Science Foundation (cstc2021jcyj-msxmX0447)

China National Cancer Center Climbing Fund (NCC201822872)

Open research fund project of Chongqing University Cancer Hospital
License Information

Text and Data Mining valid from 2023-01-07

Version of Record valid from 2023-01-07
More Information

Article History

Received: 21 March 2022

Accepted: 19 December 2022

First Online: 7 January 2023

Declarations

:

: This study was approved by the Ethics Committee of Chongqing University Cancer Hospital, and it was performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil 2013). The requirement for patients’ informed consent was waived by the Ethics Committee.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below